GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Pre-Tax Income

iCo Therapeutics (iCo Therapeutics) Pre-Tax Income : $-1.24 Mil (TTM As of Mar. 2021)


View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. iCo Therapeutics's pretax income for the three months ended in Mar. 2021 was $-0.61 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2021 was $-1.24 Mil. iCo Therapeutics's pretax margin was %.


iCo Therapeutics Pre-Tax Income Historical Data

The historical data trend for iCo Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Pre-Tax Income Chart

iCo Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.12 -0.97 -1.27 -1.47 -1.16

iCo Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.47 -0.24 -0.15 -0.25 -0.61

Competitive Comparison of iCo Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, iCo Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iCo Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iCo Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where iCo Therapeutics's Pre-Tax Income falls into.



iCo Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

iCo Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2020 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.164+0.002+0+0+0
=-1.16

iCo Therapeutics's Pretax Income for the quarter that ended in Mar. 2021 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.616+0.002+0+0+0
=-0.61

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iCo Therapeutics  (GREY:ICOTF) Pre-Tax Income Explanation

iCo Therapeutics's Pretax Margin for the quarter that ended in Mar. 2021 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.614/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iCo Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


iCo Therapeutics (iCo Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines